Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timely initiation and titration of insulin glargine in type 2 diabetes (morning vs evening)
IRCT201111283384N7Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Started Jul 2011; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201111283384N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201111283384N7.